Provident Financial Services, Inc. Logo
Provident Financial Services, Inc. Schedules Fourth Quarter and Year-End Earnings Conference Call
January 02, 2024 08:00 ET | Provident Financial Services, Inc.
ISELIN, N.J., Jan. 02, 2024 (GLOBE NEWSWIRE) -- Provident Financial Services, Inc. (NYSE: PFS) announced that it expects to release financial results for the quarter and year ended December 31, 2023...
life.jpg
LifeVantage Corporation to Participate in Water Tower Fireside Chat Series
December 11, 2023 08:00 ET | LifeVantage Corporation
SALT LAKE CITY, Dec. 11, 2023 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq:LFVN) a leading health and wellness company with products designed to activate optimal health processes, today...
Alterity.png
Alterity Therapeutics to Host Webcast to Discuss ATH434 Efficacy Data in Primates and Recent Clinical Progress
December 04, 2023 16:35 ET | ALTERITY THERAPEUTICS LIMITED
MELBOURNE, Australia and SAN FRANCISCO, Dec. 04, 2023 (GLOBE NEWSWIRE) -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) (“Alterity” or “the Company”), a biotechnology company dedicated to...
Optinose_logo_RGB.png
Optinose to Present at the 35th Annual Piper Sandler Healthcare Conference
November 22, 2023 09:00 ET | Optinose, Inc.
YARDLEY, Pa., Nov. 22, 2023 (GLOBE NEWSWIRE) -- Optinose (NASDAQ:OPTN), a pharmaceutical company focused on patients treated by ear, nose and throat (ENT) and allergy specialists, today announced...
Sarcos_Vertical-blue_2019.png
Sarcos Technology and Robotics Corporation Announces Third Quarter 2023 Financial Results
November 14, 2023 16:05 ET | Sarcos Corp.
Sarcos Technology and Robotics Corporation today announced financial results for the quarter ended September 30, 2023.
Cyclacel Pharmaceuticals logo
Cyclacel Pharmaceuticals Reports Third Quarter Financial Results and Provides Business Update
November 13, 2023 16:05 ET | Cyclacel
- Cyclacel Expects to Release Updated Phase 1/2 Clinical and Biomarker Data with Oral Fadraciclib and Provide Safety, Efficacy and Putative Mechanism Update for Oral Plogosertib - - Management to...
BWEN Logo.png
Broadwind Announces Third Quarter 2023 Results
November 13, 2023 07:00 ET | Broadwind, Inc.
CICERO, Ill., Nov. 13, 2023 (GLOBE NEWSWIRE) -- Broadwind, Inc. (Nasdaq: BWEN, “Broadwind” or the “Company”), a diversified precision manufacturer of specialized components and solutions serving...
Logo 400x400.jpg
CytoSorbents Reports Third Quarter 2023 Financial and Operational Results
November 09, 2023 16:15 ET | CytoSorbents
PRINCETON, N.J., Nov. 09, 2023 (GLOBE NEWSWIRE) -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery...
life.jpg
LifeVantage Announces Financial Results for the First Quarter of Fiscal 2024
November 09, 2023 16:05 ET | LifeVantage Corporation
SALT LAKE CITY, Nov. 09, 2023 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq: LFVN), a leading health and wellness company with products designed to activate optimal health processes, today...
exl_logo_rgb_orange_pos.jpg
EXL to Participate in J.P. Morgan 2023 Ultimate Services Investor Conference
November 09, 2023 08:30 ET | ExlService Holdings, Inc.
NEW YORK, Nov. 09, 2023 (GLOBE NEWSWIRE) -- ExlService Holdings, Inc. (“EXL”) (NASDAQ: EXLS), a leading data analytics and digital operations and solutions company, today announced that Maurizio...